We are live on ! Find out more
APEN

Apollo Endosurgery, Inc.

Delisted

APEN was delisted on the 3rd of April, 2023.

42 hedge funds and large institutions have $74.3M invested in Apollo Endosurgery, Inc. in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

700% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 2

120% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 5

68% more capital invested

Capital invested by funds: $44.2M → $74.3M (+$30.1M)

51% more call options, than puts

Call options by funds: $216K | Put options by funds: $143K

50% more funds holding

Funds holding: 2842 (+14)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
42
Holders Change
+14
Holders Change %
+50%
% of All Funds
0.74%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
16
Increased
11
Reduced
5
Closed
2
Calls
$216K
Puts
$143K
Net Calls
+$73K
Net Calls Change
+$73K

APEN Hedge Fund Activity: Q1 2021 in Review

42 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q1 2021, worth a combined $74.3M — up 68% from $44.2M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new APEN positions and 2 closed out — a net gain of 14 holders — while 11 added to existing stakes and 5 trimmed.

The largest buyer was Marshall Wace, opening a new position worth an estimated $1.86M. The largest seller was Stonepine Capital Management, cutting an estimated $4.34M.

  • 42 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q1 2021, up from 28 in Q4 2020.
  • Funds reported $74.3M of Apollo Endosurgery, Inc. stock for Q1 2021, up 68% quarter-over-quarter.
  • 16 funds opened new Apollo Endosurgery, Inc. positions in Q1 2021 and 2 closed out, a net change of +14 holders.
  • The largest Apollo Endosurgery, Inc. buyer in Q1 2021 was Marshall Wace, an estimated $1.86M added.
  • The largest Apollo Endosurgery, Inc. seller in Q1 2021 was Stonepine Capital Management, an estimated $4.34M sold.

Based on aggregated 13F filings for Q1 2021.